Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christian W. Eskelund"'
Autor:
Joana M. Rodrigues, Peter Hollander, Lina Schmidt, Eirinaios Gkika, Masoud Razmara, Darshan Kumar, Christian Geisler, Kirsten Grønbæk, Christian W. Eskelund, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Anna Porwit, Mats Jerkeman, Sara Ek
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
The transcription factor MYC is a well-described oncogene with an important role in lymphomagenesis, but its significance for clinical outcome in mantle cell lymphoma (MCL) remains to be determined. We performed an investigation of the expression of
Externí odkaz:
https://doaj.org/article/39c05dfdcc6f46b984fdbc58d95a8e72
Autor:
Simone Ferrero, Davide Rossi, Andrea Rinaldi, Alessio Bruscaggin, Valeria Spina, Christian W. Eskelund, Andrea Evangelista, Riccardo Moia, Ivo Kwee, Christina Dahl, Alice Di Rocco, Vittorio Stefoni, Fary Diop, Chiara Favini, Paola Ghione, Abdurraouf Mokhtar Mahmoud, Mattia Schipani, Arne Kolstad, Daniela Barbero, Domenico Novero, Marco Paulli, Alberto Zamò, Mats Jerkeman, Maria Gomes da Silva, Armando Santoro, Annalia Molinari, Andres Ferreri, Kirsten Grønbæk, Andrea Piccin, Sergio Cortelazzo, Francesco Bertoni, Marco Ladetto, Gianluca Gaidano
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
In recent years, the outcome of mantle cell lymphoma (MCL) has improved, especially in younger patients, receiving cytarabine-containing chemoimmunotherapy and autologous stem cell transplantation. Nevertheless, a proportion of MCL patients still exp
Externí odkaz:
https://doaj.org/article/a42fa36371644826a93ee7901afe5a7c
Autor:
Simon Husby, Cecilie Bæch-Laursen, Christian W. Eskelund, Francesco Favero, Jakob Schmidt Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten U. Niemann, Joachim Weischenfeldt, Riikka Räty, Thomas Stauffer Larsen, Arne Kolstad, Mats Jerkeman, Kirsten Grønbæk
Publikováno v:
Leukemia. 36:2912-2916
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65dedd289c51def807296ecf097bcde0
https://doi.org/10.1038/s41375-022-01725-8
https://doi.org/10.1038/s41375-022-01725-8
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Primary plasma cell leukaemia (pPCL) is a rare and aggressive form of plasma cell malignancies with a very poor prognosis. Compared to other plasma cell malignancies the tendency to extramedullary spread is increased; however central nervous system (
Externí odkaz:
https://doaj.org/article/94075983dcfb44fc81d94bd5958abd76
Autor:
Mette, Dahl, Simon, Husby, Christian W, Eskelund, Søren, Besenbacher, Søren, Fjelstrup, Christophe, Côme, Sara, Ek, Arne, Kolstad, Riikka, Räty, Mats, Jerkeman, Christian H, Geisler, Jørgen, Kjems, Lasse S, Kristensen, Kirsten, Grønbæk
Publikováno v:
Leukemia. 36(1)
Mantle cell lymphoma (MCL) is characterized by marked differences in outcome, emphasizing the need for strong prognostic biomarkers. Here, we explore expression patterns and prognostic relevance of circular RNAs (circRNAs), a group of endogenous non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2ecc3cd8d131349281402c2afc967c4
https://pubmed.ncbi.nlm.nih.gov/35181760
https://pubmed.ncbi.nlm.nih.gov/35181760
Autor:
Marianne Hokland, Anne Stidsholt Roug, Line Nederby, Anni Skovbo, Christian W. Eskelund, Anna Hammerich Thysen
Publikováno v:
Eskelund, C W, Nederby, L, Thysen, A H, Skovbo, A, Roug, A S & Hokland, M E 2011, ' Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia ', Leukemia Research, vol. 35, no. 7, pp. 914-20 . https://doi.org/10.1016/j.leukres.2011.02.006
We have examined natural killer (NK) cell functionality of 54 B-CLL patients upon in vitro stimulation with interleukin-21 (IL-21), together with the anti-CD20 antibody, rituximab. Upon stimulation with rituximab-coated target cells IFN-γ production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b966c29f1e1e2303de800527231d05
https://pubmed.ncbi.nlm.nih.gov/21354618
https://pubmed.ncbi.nlm.nih.gov/21354618
Autor:
Marianne Hokland, Line Petersen, Anni Skovbo, Christian W. Eskelund, Anne Stidsholt Roug, Anna Hammerich Thysen
Publikováno v:
Petersen, L, Roug, A S, Skovbo, A, Thysen, A H, Eskelund, C W & Hokland, M 2009, ' The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus ', Viral Immunology, vol. 22, no. 5, pp. 333-7 . https://doi.org/10.1089/vim.2009.0032
Udgivelsesdato: 2009-Oct Human cytomegalovirus (HCMV) manipulates the host immune system in various ways. Allegedly, HCMV infection is associated with increased percentages of a particular natural killer (NK) cell subset expressing the activating rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf6a742c2b26d6fd546f0e2380c0fc0
https://pure.au.dk/portal/da/publications/the-cd94nkg2cexpressing-nk-cell-subset-is-augmented-in-chronic-lymphocytic-leukemia-patients-with-positive-human-cytomegalovirus-serostatus(4e1f1bc0-cde5-11de-a30a-000ea68e967b).html
https://pure.au.dk/portal/da/publications/the-cd94nkg2cexpressing-nk-cell-subset-is-augmented-in-chronic-lymphocytic-leukemia-patients-with-positive-human-cytomegalovirus-serostatus(4e1f1bc0-cde5-11de-a30a-000ea68e967b).html
Autor:
Line Petersen, Anne S. Roug, Anni Skovbo, Anna H. Thysen, Christian W. Eskelund, Marianne E. Hokland
Publikováno v:
Viral Immunology; Oct2009, Vol. 22 Issue 5, p333-337, 5p